If they continue Reduce-it they will need much more cash before the end of 2014. They will most likely show a cash burn well over $40M for the last qtr alone. It does not have to be leaked. The horrible number is already expected. In addition Rx growth has already stalled to zero and this is even before the sales force cut in half. joe Z will most certainly be asked if bankruptcy is an option and I'm sure that Joa Z will simply say that ALL options are on the table. These guys cannot capture but 5% of Lovaza share after an entire year at equal pricing. They have zero chance of selling vs generic Lovaza which will be 70-80% cheaper! This ship is under water deeper than the Titanic.
That $220M will be in the $170-$175M range after next weeks report and the cash burn will only gradually slow. Even cost of goods projections were based on volume discounts anticipated by an Anchor expansion which is now also gone. There will be no good news on the call. Joe Z will be on the defensive the entire call and will most likely flounder as he usually does. Maybe he will say the next 60-90 days will NOT be very exciting. He is the worst CEO since Enron!
Actually they said approx $226 mil on 9-30-13, put you were close enough. They said the burn would be less than $80 mil in 2014. Maybe they'll shed some light on Q4 cash burn rate along w/ the EPS report.